submicroscopic chromosomal abnormalities of the subtelomeres
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Only if amniocentesis is already planned because of abnormal ultrasonographic findings of the fetus, future parents will be asked for this study. The MLPA-test will only be performed if the karyotyping is normal.
Exclusion criteria
Exclusion criteria: Abnormal fetal karyotype that can explain the ultrasonographic anomalies. Absence of a signed informed consent by both parents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall percentage of submicroscopic chromosomal abnormalities( microdeletions or -duplications) in fetuses with structural malformations and a normal routine karyotyping | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Percentage of relevant submicroscopic chromosomal abnormalities with known clinical implications versus the percentage of unknown abnormalities with unclear clinical implications in fetuses with structural malformations and normal routine karyotyping? 2. Can we ascertain an association between the fetal malformation and the detected submicroscopic chromosomal abnormality? | — |
Countries
Netherlands